Skip to content

CROI: Do boosted protease inhibitors have a lower risk of treatment failure than other regimens?

CROI: Lipodystrophy stable in children on HIV treatment and does not resolve after stopping d4T

CROI: Low rates of resistance seen in Staccato trial of CD4-guided treatment interruptions

CROI: Studies begin to identify genes linked to metabolic and body fat changes

CROI: Wasting and anaemia predict higher risk of death when starting ART in low-income countries

Simultaneous HIV therapy and chemotherapy for lymphoma effective and safe

HIV and malaria: when elephants collide

France proposes air ticket levy to fund HIV drugs

HAART reduces AIDS events even when treatment response is poor

CROI: Studies look at tipranavir/ritonavir's potency and pharmacokinetics

CROI: Many patients still gaining CD4 cells after seven years of HAART

Restoration of CD4 T-cells limited in children starting HIV treatment at low CD4 percentages

CROI: More data on role of antiretrovirals, interventions, HCV, in cardiovascular disease risk

Ukraine: anti-AIDS efforts undermined by human rights abuses

CROI: Early vs delayed Trizivir in TB/HIV coinfected - no difference in rate of IRIS

Best results in HIV-positive children if treatment started before five months of age

Merck announces 20% cut in efavirenz price for low and middle-income countries

New directions in HIV prevention: circumcision and PREP